期刊文献+

术后综合治疗高级别胶质瘤89例分析 被引量:2

下载PDF
导出
摘要 脑胶质瘤是脑内最常见的肿瘤,约占脑肿瘤半数以上,其中以间变型星形细胞瘤和胶质母细胞瘤的恶性程度较高,且具有高复发率和高病死率的特点。临床上的主要治疗方法是在手术治疗基础上辅以放疗和化疗,即使如此肿瘤仍会很快复发。其中胶质母细胞瘤患者一般平均存活仅10~12个月,大多数在确诊后1年半左右死亡[1]。
出处 《中国药物与临床》 CAS 2012年第4期491-493,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献4

  • 1Salcman M,Scholtz H,Kaplan RS. Long-term survival in patients with malignant astrocytoma[J].Neurosurgery,1994,(02):213-220.
  • 2Walker MD,Alexander E Jr,Hunt WE. Evaluation of BC-NU and/or radiotherapy in the treatment of anaplastic gliomas:a cooperative clinical trial[J].Journal of Neurosurgery,1978,(03):333-343.
  • 3Medical Research Council Brain Tumor Working Party. Random-ized trial of procarbazine,lomustine,and vincristine in the adju-vant treatment of high-grade astrocytoma:a medical research council trial[J].Journal of Clinical Oncology,2001,(02):509-518.
  • 4Stupp R,Hegi ME,Mason WP. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J].Lancet Oncology,2009,(05):459-466.

同被引文献24

  • 1王煜,雷霆,牛洪泉,董震,董芳永,柳再明,薛德麟.树突状细胞瘤内注射和化疗联合治疗脑胶质瘤的实验研究[J].中华神经外科杂志,2006,22(3):184-186. 被引量:11
  • 2Bauman G, Lote K, Larson D, et al. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis[J]. Int J Radiat Oncol Biol Phys, 1999, 45(4): 923-929.
  • 3Nelson DF, Curran WJ, Scott C, et al. Hyperfractionated radi- ation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma possible advantage observed at 72. 0 Gy in 1.2 Gy BID fractions: report of the Radiation Therapy On- tology Group Protocol 8302[J]. Int J Radiat Oncol Biol Phys, 1993,25(2) : 193-207.
  • 4Youland RS, Brown PD, Giannini C, et al. Adult low-grade glioma: 19-year experience at a single institution[J]. Am J Clin Oncol, 2013, 36(6) :612-619.
  • 5McGirt MJ,Chaichana KL,Gathinji M,et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma[J]. J Neurosurg, 2009,110 ( 1 ) :156-162.
  • 6Tamura K, Aoyagi M, Wakimoto H, et al. Accumulation of CD133-positive glioma cells after high dose irradiation by gamma knife surgery plus external beam radiation[J]. J Neurosurg, 2010, 113(12): 310-318.
  • 7Chibbaro S, Benvenuti L, Capfio A, et al. Temozolomide as first-line agent in treating high-grade gliomas: phase study [J]. Neurooneol ,2004, 67 (1/2): 77-81.
  • 8Muragaki Y, Akimoto J, Maruyama T, et al. Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodi- um and semiconductor laser in patients with malignant brain tumors [J~. J Neurosurg,2013,119(4) :845-852.
  • 9Thomas AA, Brennan CW, DeAngelis LM, et al, Emerging thera- pies for glioblastoma [ J~. JAMA Neurol, 2014 , 71 ( 11 ) : 1437-1444.
  • 10Bae SH, Park MJ, Lee MM, et al. Toxicity profile of temozolo- mide in the treatment of 300 malignant glioma patients in Korea [J]. J Korean Med Sei,2014,29(7) :980-984.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部